1. Guideline on Risk Management Systems For Medicinal Products For Human Use, 14 November 2005. http://www.emea.europa.eu/pdfs/human/euleg/9626805en.pdf. Accessed 13 January 2009.
2. Guidance for Industry: Development and Use of Risk Minimization Action Plans, March 2005. http://www.fda.gov/cder/guidance/6358fnl.htm. Accessed 13 January 2009.
3. Risk management planning: time to deliver;Waller;Pharmacoepidemiol Drug Saf,2006
4. ICH Harmonised Tripartite Guideline: Pharmacovigilance planning (E2E), 18 November 2004. http://www.ich.org/LOB/media/MEDIA1195.pdf. Accessed 13 January 2009.
5. Adverse events following immunization: perception and evidence;Bonhoeffer;Curr Opin Infect Dis,2007